TENNANT CO — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that TENNANT CO filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $294.80M | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | $280.70M | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | $299.70M | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | $262.50M | Feb 27, 2020 |
| FY2019 | Dec 31, 2018 | $285.20M | Feb 27, 2020 |
| FY2019 | Sep 30, 2018 | $273.30M | Feb 27, 2020 |
| FY2019 | Jun 30, 2018 | $292.20M | Feb 27, 2020 |
| FY2019 | Mar 31, 2018 | $272.80M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $279.30M | Feb 28, 2019 |
| FY2018 | Sep 30, 2017 | $261.92M | Feb 28, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.20B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $1.29B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $1.24B | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $1.09B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $1.09B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $1.00B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $1.14B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $1.12B | Feb 25, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $1.00B | Feb 28, 2018 |
| FY2017 | Dec 31, 2016 | $279.30M | Feb 28, 2018 |
| FY2017 | Sep 30, 2016 | $261.92M | Feb 28, 2018 |
| FY2017 | Jun 30, 2016 | $270.79M | Feb 28, 2018 |
| FY2017 | Mar 31, 2016 | $191.06M | Feb 28, 2018 |
| FY2017 | Dec 31, 2015 | $211.75M | Feb 28, 2018 |
| FY2017 | Sep 30, 2015 | $200.13M | Feb 28, 2018 |
| FY2017 | Jun 30, 2015 | $216.83M | Feb 28, 2018 |
| FY2017 | Mar 31, 2015 | $179.86M | Feb 28, 2018 |
| FY2015 | Dec 31, 2014 | $216.28M | Feb 29, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $484.30M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $550.00M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $527.80M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $420.90M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $438.00M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $407.80M | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | $118.60M | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | $114.00M | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | $120.80M | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | $108.20M | Feb 27, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $43.80M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $83.70M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $109.50M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $66.30M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $64.90M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $33.70M | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | $10.90M | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | $14.60M | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | $14.80M | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | $5.40M | Feb 27, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $68.30M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $114.30M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $138.60M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $87.20M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $93.70M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $63.70M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $71.80M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $58.00M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $33.00M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $68.27M | Feb 28, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $41.20M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $43.80M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $36.60M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $31.10M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $32.20M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $30.10M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $32.70M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $30.70M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $32.00M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $34.74M | Feb 28, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $374.80M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $391.90M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $352.60M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $306.30M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $321.90M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $314.00M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $357.20M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $356.30M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $334.80M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $248.59M | Feb 28, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $65.00M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $89.70M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $188.40M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | ($25.10M) | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $69.40M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $133.80M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $71.90M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $80.00M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $54.20M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $57.88M | Feb 28, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.70M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $20.90M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $22.80M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $25.00M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $19.40M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $29.90M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $38.40M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $18.80M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $20.40M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $26.53M | Feb 28, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.27B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $1.19B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $1.11B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $1.09B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $1.06B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $1.08B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $1.06B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $992.50M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $993.98M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $470.04M | Feb 28, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $665.50M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $568.00M | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $535.10M | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $613.00M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $626.60M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $676.50M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $701.60M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $676.20M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $695.50M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $191.49M | Feb 28, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $601.60M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $620.80M | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $577.00M | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $470.80M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $433.80M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $404.80M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $359.90M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $314.40M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $296.50M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $278.54M | Feb 28, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $208.60M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $185.60M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $187.40M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $182.00M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $193.10M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $207.80M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $195.10M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $182.70M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $186.00M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $21.07M | Feb 28, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $628.10M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $609.70M | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $547.40M | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $458.00M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $410.60M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $363.30M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $346.00M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $316.30M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $297.03M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $318.18M | Feb 28, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $85.61M | Feb 28, 2019 |
| FY2018 | Dec 31, 2017 | $58.40M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $58.03M | Feb 28, 2018 |
| FY2017 | Dec 31, 2015 | $51.30M | Feb 28, 2018 |
| FY2017 | Dec 31, 2014 | $92.96M | Feb 28, 2018 |
| FY2016 | Dec 31, 2013 | $80.98M | Mar 1, 2017 |
| FY2015 | Dec 31, 2012 | $53.94M | Feb 29, 2016 |
| FY2014 | Dec 31, 2011 | $52.34M | Feb 27, 2015 |
| FY2013 | Dec 31, 2010 | $39.53M | Feb 28, 2014 |
| FY2012 | Dec 31, 2009 | $18.06M | Feb 22, 2013 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $273.60M | Feb 24, 2026 |
| FY2024 | Dec 31, 2024 | $199.50M | Feb 18, 2025 |
| FY2023 | Dec 31, 2023 | $200.60M | Feb 22, 2024 |
| FY2022 | Dec 31, 2022 | $300.30M | Feb 23, 2023 |
| FY2021 | Dec 31, 2021 | $267.60M | Feb 24, 2022 |
| FY2020 | Dec 31, 2020 | $311.60M | Feb 25, 2021 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 4 | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | 5 | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 27, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 4 | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | 5 | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 27, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 17.85M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 18.85M | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | 18.63M | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | 18.52M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | 18.54M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | 18.50M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | 18.34M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | 18.13M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | 17.88M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | 17.69M | Feb 28, 2018 |